Interindividual variability in the expression and NNK carbonyl reductase activity of 11β-hydroxysteroid dehydrogenase 1 in human lung

Cancer Letters

Volumn 145, Issue 1-2, 1999, Pages 49-56

  Soldan, Michael ^a   Nagel, Gerd ^a   Losekam, Marga ^a   Ernst, Michael ^b   Maser, Edmund ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

11 Hydroxysteroid dehydrogenase; 4 (Methylnitrosamino) 1 (3 pyridyl) 1 butanone; Carbonyl reduction; Detoxification; Human lung; NNK

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBONYL REDUCTASE;

ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; LUNG CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; AGED; FEMALE; HUMANS; HYDROXYSTEROID DEHYDROGENASES; LUNG; LUNG NEOPLASMS; MALE; METABOLIC DETOXICATION, DRUG; MICROSOMES; MIDDLE AGED; PROTEINS; RISK FACTORS; RNA, MESSENGER; SMOKING;

NICOTIANA TABACUM;

EID: 0032888379     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00216-5     Document Type: Article

References (39)

1. Boring C.C., Squires T.S., Tong T., Montgomery S. Cancer Statistics, 1994. CA Cancer J. Clin. 44:1994;7-26.
2. Wynder E.L., Hoffmann D. Smoking and lung cancer: scientific challenges and opportunities. Cancer Res. 54:1994;5284-5295.
3. Hecht S.S., Chen C.B., Ohmori T., Hoffmann D. Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines N-nitroso-nornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 40:1980;298-302.
4. Burton H.R., Childs G.H., Anderson R.A., Fleming P.D. Changes in chemical composition of Burley tobacco during senescence and curing. 3. Tobacco specific nitrosamines. J. Agric. Food Chem. 37:1989;426-430.
5. Hecht S.S., Hoffmann D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv. 8:1989;273-294.
6. Crespi C.L., Penman B.W., Gelboin H.V., Gonzalez F.J. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis. 12:1991;1197-1201.
7. Hecht S.S. Metabolic activation and detoxification of tobacco-specific nitrosamines - a model for cancer prevention strategies. Drug Metab. Rev. 26:1994;373-390.
8. Carmella S.G., Borukhova A., Akerkar S.A., Hecht S.S. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Cancer Epidemiol. Biomarkers Prev. 6:1997;113-120.
9. Smith T.J., Guo Z., Gonzalez F.J., Guengerich F.P., Stoner G.D., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res. 52:1992;1757-1763.
10. Smith T.J., Liao A.M., Liu Y., Butler Jones A., Anderson L.M., Yang C.S. Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes. Carcinogenesis. 18:1997;1577-1584.
11. Smith T.J., Stoner G.D., Yang C.S. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroxyperoxides. Cancer Res. 55:1995;5566-5573.
12. Maser E. 11β-Hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes. Cancer Res. 58:1998;2996-3003.
13. Schulze J., Richter E., Binder U., Zwickenpflug W. Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat. Carcinogenesis. 13:1992;1961-1965.
14. Hecht S.S., Trushin N., Reid Quinn C.A., Burak E.S., Jones A.B., Southers J.L., Gombar C.T., Carmella S.G., Anderson L.M., Rice J.M. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis. 14:1993;229-236.
15. Carmella S.G., Akerkar S., Hecht S.S. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res. 53:1993;721-724.
16. Hecht S.S., Carmella S.G., Murphy S.E., Akerkar S., Brunnemann K.D., Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N. Engl. J. Med. 329:1993;1543-1546.
17. Murphy S.E., Carmella S.G., Idris A.M., Hoffmann D. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Cancer Epidemiol. Biomarkers Prev. 3:1994;423-428.
18. Maser E., Richter E., Friebertshauser J. The identification of 11β-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur. J. Biochem. 238:1996;484-489.
19. Maser E., Bannenberg G. 11β-Hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds. Biochem. Pharmacol. 47:1994;1805-1812.
20. Maser E., Bannenberg G. The purification of 11β-hydroxysteroid dehydrogenase from mouse liver microsomes. J. Steroid Biochem. Mol. Biol. 48:1994;257-263.
21. Maser E. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? Trends Pharmacol. Sci. 18:1997;270-275.
22. Maser E., Oppermann U.C.T. Role of type-1 11β-hydroxysteroid dehydrogenase in detoxification processes. Eur. J. Biochem. 249:1997;356-369.
23. Maser E. 11β-Hydroxysteroid dehydrogenase acts as carbonyl reductase in microsomal phase I drug metabolism. Exp. Toxicol. Pathol. 48:1996;266-273.
24. Oppermann U.C.T., Netter K.J., Maser E. Cloning and primary structure of murine 11β-hydroxysteroid dehydrogenase/microsomal carbonyl reductase. Eur. J. Biochem. 227:1995;202-208.
25. Carmella S.G., Akerkar S.A., Richie J.P., Hecht S.S. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smoker's urine. Cancer Epidemiol. Biomarkers Prev. 4:1995;635-652.
26. Meger M., Meger-Kossien I., Dietrich M., Tricker A.R., Scherer G., Adlkofer F. Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in urine of smokers. Eur. J. Cancer Prev. 5 Suppl. 1:1996;121-124.
27. Castonguay A., Lin D., Stoner G.D., Radok P., Furuya K., Hecht S.S., Schut H.A.J., Klaunig J.E. Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and their analogues. Cancer Res. 43:1983;1223-1229.
28. London S.J., Daly A.K., Leathart J.B., Navidi W.C., Carpenter C.C., Idle J.R. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis. 18:1997;1203-1214.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. Osann K.E. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res. 51:1991;4893-4897.
31. Lynch H.T., Kimberling W.J., Markvicka S.E., Biscone K.A., Lynch J.F., Whorton E.J., Mailliard J. Genetics and smoking-associated cancers. Cancer. 57:1986;1640-1646.
32. Wu A.H., Fontham E.T.H., Reynolds P., Greenberg R.S., Buffler P., Liff J., Boyd P., Correa P. Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am. J. Epidemiol. 143:1996;535-542.
33. Schwartz A.G., Yang P., Swanson G.M. Familial risk of lung cancer among nonsmokers and their relatives. Am. J. Epidemiol. 144:1996;554-562.
34. Guo Z., Smith T.J., Thomas P.E., Yang C.S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. Arch. Biochem. Biophys. 298:1992;279-286.
35. Weaver J.U., Taylor N.F., Monson J.P., Wood P.J., Kelly W.F. Sexual dimorphism in 11β-hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects. Clin. Endocrinol. Oxf. 49:1998;13-20.
36. Low S.C., Chapman K.E., Edwards C.R., Wells T., Robinson I.C., Seckl J.R. Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J. Endocrinol. 143:1994;541-548.
37. Zang E.A., Wynder E.L. Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers. Cancer. 70:1992;69-76.
38. Risch H.A., Howe G.R., Jain M., Burch J.D., Holowaty E.J., Miller A.B. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am. J. Epidemiol. 138:1993;281-293.
39. Osann K.E., Anton-Culver H., Kurosaki T., Taylor T. Sex differences in lung cancer risk associated with cigarette smoking. Int. J. Cancer. 54:1993;44-48.